Cargando…
COVID-19 Diagnostic Strategies Part II: Protein-Based Technologies
After the initiation of the current outbreak, humans’ lives have been profoundly impacted by COVID-19. During the first months, no rapid and reliable detecting tool was readily available to sufficiently respond to the requirement of massive testing. In this situation, when the development of an effe...
Autores principales: | Shaffaf, Tina, Ghafar-Zadeh, Ebrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145709/ https://www.ncbi.nlm.nih.gov/pubmed/33925032 http://dx.doi.org/10.3390/bioengineering8050054 |
Ejemplares similares
-
COVID-19 Diagnostic Strategies. Part I: Nucleic Acid-Based Technologies
por: Shaffaf, Tina, et al.
Publicado: (2021) -
Towards Fully Integrated Portable Sensing Devices for COVID-19 and Future Global Hazards: Recent Advances, Challenges, and Prospects
por: Shaffaf, Tina, et al.
Publicado: (2021) -
Microbiological Sensing Technologies: A Review
por: Abbasian, Firouz, et al.
Publicado: (2018) -
Wireless Integrated Biosensors for Point-of-Care Diagnostic Applications
por: Ghafar-Zadeh, Ebrahim
Publicado: (2015) -
Recent Advances of Field-Effect Transistor Technology for Infectious Diseases
por: Panahi, Abbas, et al.
Publicado: (2021)